Argentina Vaccination Coverage and Dengue Update – December 23, 2025

Argentina is actively monitoring and addressing vaccination coverage rates for key diseases, alongside ongoing surveillance for dengue fever. Recent data reveals varying levels of immunization across the country, with specific attention being paid to booster doses. Dengue transmission risk remains low nationally, according to the Ministry of Health.

Vaccination Coverage Rates

National vaccination schedules are crucial for preventing the spread of infectious diseases. recent analysis of coverage rates provides insights into the effectiveness of these programs and areas needing improvement.

Basic Vaccination Schedules

coverage rates for the basic vaccination schedule are generally high.The report indicates 80.48% coverage for the first dose, 77.71% for the second dose, and 73.74% for the third dose.

Booster Dose Coverage

booster doses are essential for maintaining immunity over time. Coverage rates for booster doses vary by age group:

• 15-18 months: 64.15%
• 5 years: 76.8%
• 11 years: 77.6%
• Pregnant Women: 72.71%

Regional Variations

Significant differences in vaccination coverage exist across Argentina’s provinces. provinces with high coverage include Tierra del Fuego,La Pampa,Jujuy,Neuquén,Mendoza,and San Juan. Intermediate or low coverage levels were observed in Buenos Aires, CABA (Autonomous City of Buenos Aires), Formosa, Santa Fe, Corrientes, and Misiones, notably concerning booster doses.

Dengue Fever Surveillance

Dengue fever is a mosquito-borne viral infection that can cause significant illness. Argentina’s Ministry of Health continuously monitors dengue cases to prevent outbreaks.

During the last week, 489 suspected cases of dengue were reported, but none were confirmed. The Ministry of Health’s report indicates that the situation remains within a curve of low risk of transmission.Argentina’s Ministry of Health provides regular updates and guidance on dengue prevention.

Key Takeaways

• National vaccination coverage for basic schedules is generally high, exceeding 73%.
• Booster dose coverage requires attention, particularly in specific age groups and regions.
• Regional disparities in vaccination coverage necessitate targeted interventions.
• Dengue transmission risk remains low nationally, but continued surveillance is crucial.

Continued efforts to improve vaccination coverage, especially booster doses, and maintain vigilant dengue surveillance are essential for protecting public health in Argentina. Future reports will provide updated data and inform ongoing public health strategies.